Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Infliximab in the management of severe pemphigus vulgaris.

Literature DB >> 16029365

Infliximab in the management of severe pemphigus vulgaris.

J Pardo, P Mercader, L Mahiques, J L Sanchez-Carazo, V Oliver, J M Fortea.

Abstract

Mesh：

Substances：

Year: 2005 PMID： 16029365 DOI： 10.1111/j.1365-2133.2005.06672.x

Source DB: PubMed Journal: Br J Dermatol ISSN： 0007-0963 Impact factor: 9.302

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

1. Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment.

Authors: Elizabeth A Mauldin; Daniel O Morris; Dorothy C Brown; Margret L Casal
Journal: Vet Dermatol Date: 2010-04-01 Impact factor: 1.589

Review 2. [Pemphigus. Model disease for targeted therapy].

Authors: R Eming
Journal: Hautarzt Date: 2015-08 Impact factor: 0.751

Review 3. Seeking approval: present and future therapies for pemphigus vulgaris.

Authors: Xuming Mao; Aimee S Payne
Journal: Curr Opin Investig Drugs Date: 2008-05

4. A multicentre randomized trial of the treatment of patients with pemphigus vulgaris with infliximab and prednisone compared with prednisone alone.

Authors: R P Hall; J Fairley; D Woodley; V P Werth; D Hannah; R D Streilein; J McKillip; J Okawa; M Rose; L L Keyes-Elstein; A Pinckney; A Overington; J Wedgwood; L Ding; B Welch
Journal: Br J Dermatol Date: 2015-02-05 Impact factor: 9.302

5. Reduced skin blistering in experimental epidermolysis bullosa acquisita after anti-TNF treatment.

Authors: Misa Hirose; Anika Kasprick; Foteini Beltsiou; Katharina Dieckhoff Schulze; Franziska Sophine Schulze; Unni Kjsrl Samavedam; Jennifer E Hundt; Hendri H Pas; Marcel F Jonkman; Enno Schmidt; Kathrin Kalies; Detlef Zillikens; Ralf J Ludwig; Katja Bieber
Journal: Mol Med Date: 2016-12-20 Impact factor: 6.354

6. A hypothesis concerning a potential involvement of ceramide in apoptosis and acantholysis induced by pemphigus autoantibodies.

Authors: Wendy B Bollag
Journal: Dermatol Res Pract Date: 2010-05-18

Infliximab in the management of severe pemphigus vulgaris.

1. Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment.

Review 2. [Pemphigus. Model disease for targeted therapy].

Review 3. Seeking approval: present and future therapies for pemphigus vulgaris.

4. A multicentre randomized trial of the treatment of patients with pemphigus vulgaris with infliximab and prednisone compared with prednisone alone.

5. Reduced skin blistering in experimental epidermolysis bullosa acquisita after anti-TNF treatment.

6. A hypothesis concerning a potential involvement of ceramide in apoptosis and acantholysis induced by pemphigus autoantibodies.

Review 7. Novel therapies for pemphigus vulgaris: an overview.

Review 8. Refractory pemphigus foliaceus and Behçet's disease successfully treated with tocilizumab.

Review 9. Pemphigus autoimmunity: hypotheses and realities.

Review 10. Management of pemphigus vulgaris: challenges and solutions.